T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,689 | 10,329 | 22,245 | 16,793 | 11,033 |
| Marketable Securities | N/A | N/A | 9,996 | 25,396 | 0 |
| Receivables | 1,420 | 2,163 | 5,134 | 5,099 | 2,825 |
| Inventories | 4,819 | 4,285 | 3,909 | 3,636 | 3,599 |
| TOTAL | $25,189 | $19,359 | $44,394 | $53,584 | $18,895 |
| Non-Current Assets | |||||
| PPE Net | 1,658 | 4,533 | 4,675 | 3,771 | 5,845 |
| Investments And Advances | 0 | 0 | 0 | 10,002 | 0 |
| Other Non-Current Assets | 7,950 | 10,435 | 11,470 | 11,721 | 3,746 |
| TOTAL | $9,608 | $14,968 | $16,145 | $25,494 | $9,591 |
| Total Assets | $34,797 | $34,327 | $60,539 | $79,078 | $28,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,527 | 1,296 | 2,832 | 2,058 | 3,753 |
| Accrued Expenses | 9,712 | 7,269 | 7,164 | 7,512 | 11,207 |
| Other current liabilities | 1,789 | 39 | N/A | N/A | 2,425 |
| TOTAL | $56,152 | $10,128 | $11,688 | $9,800 | $60,572 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 49,651 | 47,790 | 45,235 | 0 |
| Deferred Revenues | 224 | 172 | 518 | 230 | 285 |
| Other Non-Current Liabilities | 6,598 | 14,151 | 13,936 | 14,893 | 1,873 |
| TOTAL | $6,681 | $63,854 | $61,754 | $60,552 | $1,919 |
| Total Liabilities | $62,833 | $73,982 | $73,442 | $70,352 | $62,491 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,512 | 203 | 34 | 30 | 20 |
| Common Shares | 4 | N/A | 3 | 148 | 51 |
| Retained earnings | -584,296 | -534,219 | -472,216 | -422,975 | -376,177 |
| Other shareholders' equity | 0 | 0 | -4 | 9 | 0 |
| TOTAL | $-28,036 | $-39,655 | $-12,903 | $8,726 | $-34,005 |
| Total Liabilities And Equity | $34,797 | $34,327 | $60,539 | $79,078 | $28,486 |